Literature DB >> 35706464

Empirical evaluation of sub-cohort sampling designs for risk prediction modeling.

Myeonggyun Lee1, Anne Zeleniuch-Jacquotte1,2, Mengling Liu1,2.   

Abstract

Sub-cohort sampling designs, such as nested case-control (NCC) and case-cohort (CC) studies, have been widely used to estimate biomarker-disease associations because of their cost effectiveness. These designs have been well studied and shown to maintain relatively high efficiency compared to full-cohort designs, but their performance of building risk prediction models has been less studied. Moreover, sub-cohort sampling designs often use matching (or stratifying) to further control for confounders or to reduce measurement error. Their predictive performance depends on both the design and matching procedures. Based on a dataset from the NYU Women's Health Study (NYUWHS), we performed Monte Carlo simulations to systematically evaluate risk prediction performance under NCC, CC, and full-cohort studies. Our simulations demonstrate that sub-cohort sampling designs can have predictive accuracy (i.e. discrimination and calibration) similar to that of the full-cohort design, but could be sensitive to the matching procedure used. Our results suggest that researchers can have the option of performing NCC and CC studies with huge potential benefits in cost and resources, but need to pay particular attention to the matching procedure when developing a risk prediction model in biomarker studies.
© 2020 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Calibration; case-cohort; discrimination accuracy; matching; nested case–control; risk prediction

Year:  2020        PMID: 35706464      PMCID: PMC9042011          DOI: 10.1080/02664763.2020.1861225

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  45 in total

1.  Exposure stratified case-cohort designs.

Authors:  O Borgan; B Langholz; S O Samuelsen; L Goldstein; J Pogoda
Journal:  Lifetime Data Anal       Date:  2000-03       Impact factor: 1.588

2.  Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Authors:  Wenzhen Ge; Tess V Clendenen; Yelena Afanasyeva; Karen L Koenig; Claudia Agnoli; Louise A Brinton; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2018-02-08       Impact factor: 7.396

3.  Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide.

Authors:  Kevin McGeechan; Petra Macaskill; Les Irwig; Gerald Liew; Tien Y Wong
Journal:  Arch Intern Med       Date:  2008-11-24

4.  Evaluating prognostic accuracy of biomarkers in nested case-control studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  Biostatistics       Date:  2011-08-19       Impact factor: 5.899

5.  On estimation of linear transformation models with nested case-control sampling.

Authors:  Wenbin Lu; Mengling Liu
Journal:  Lifetime Data Anal       Date:  2011-09-13       Impact factor: 1.588

6.  Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative.

Authors:  Nancy R Cook; Nina P Paynter; Charles B Eaton; JoAnn E Manson; Lisa W Martin; Jennifer G Robinson; Jacques E Rossouw; Sylvia Wassertheil-Smoller; Paul M Ridker
Journal:  Circulation       Date:  2012-03-07       Impact factor: 29.690

7.  Coronary artery calcium score and risk classification for coronary heart disease prediction.

Authors:  Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

8.  Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Authors:  Michael J Pencina; Ralph B D'Agostino; Martin G Larson; Joseph M Massaro; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

9.  Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.

Authors:  Tess V Clendenen; Wenzhen Ge; Karen L Koenig; Yelena Afanasyeva; Claudia Agnoli; Louise A Brinton; Farbod Darvishian; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Anne Zeleniuch-Jacquotte; Mengling Liu
Journal:  Breast Cancer Res       Date:  2019-03-19       Impact factor: 6.466

10.  Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

Authors:  Wouter de Ruijter; Rudi G J Westendorp; Willem J J Assendelft; Wendy P J den Elzen; Anton J M de Craen; Saskia le Cessie; Jacobijn Gussekloo
Journal:  BMJ       Date:  2009-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.